Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditSelection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina FasoEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesProtective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialArtemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialPopulation Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned.Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT intervalEffect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infantsConsent and assent in paediatric research in low-income settings.Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohortImported malaria in pregnant women: A retrospective pooled analysisIntermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspectiveRandomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoRethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an opOperational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey.Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi.A non-pharmaceutical form of Artemisia annua is not effective in preventing Plasmodium falciparum malaria.The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study.Comparative effectiveness of malaria prevention measures: a systematic review and network meta-analysis.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysisDelivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial
P2860
Q21032449-9D4EC73B-FBE1-4D6D-8C5C-B975B341CA0DQ28125901-D02D8AB1-CEDD-4664-8803-F5C828859911Q28535686-695F352B-B730-4CD7-863A-704C6997B862Q28541598-D4A4C468-A782-459E-A2C6-3C2F39B75DE7Q28542921-9019D57F-6A43-4975-A91B-454BE1E9CF95Q31153944-CE01FABB-9FFB-4806-A8FA-792496B9B900Q33601831-7A055B80-1642-4E24-BA8A-358EBCC6A88AQ33622892-A9DE91AB-1101-4F42-AEAE-D039AD7FEDC4Q33721927-220452EC-164C-4DE4-AEB8-95FC70871AFBQ34057403-53534D16-036E-460E-B8CC-77FF0C03785DQ34298973-4EAD201D-87DC-4BFC-82C9-34DCBCA75B47Q34299178-31DAA76B-4987-43D6-989C-338760897D3AQ35055212-DD7D762B-8016-4275-AA76-9C4BF8B89354Q35111842-1C41DACC-06E6-496A-809E-912CFE1ECFF3Q35667005-DEF0C37A-17FC-4B9A-960D-E8C2E141703BQ35727968-FD26F635-03F8-4B44-AC1F-24AC8D9ABE96Q35759333-5D6A7ABD-1D3A-4589-B8E0-4739E060D2F4Q35859844-BD1DA58B-4F83-4FB1-84B3-2952E52C1D35Q36018444-2AC46AB2-9650-4CDF-83C6-3CC462B673D1Q36092227-459CE2CF-652C-478E-8902-9A4F16F57988Q36478633-EA8A057E-CE14-4DA1-80B8-0E50C2DC4F70Q36667896-DC068103-7857-4EDF-8467-169EA0CB45E7Q36843561-E04568B7-A8A4-4D4D-A242-624F44B77D99Q37564052-18FE6974-D5B1-40C0-B255-FD25F04371D7Q37607325-3EB63FDB-431D-458D-A98A-1ADFE041B133Q37726083-CF1D5BCB-74B7-485B-9A23-9B40A515435FQ38399949-E9158DB7-6D44-4DC4-ACEC-490A19BB5030Q38684764-13987FBA-DC7A-41A1-84A3-F314A4A7379BQ38850820-CEF021B4-7EE9-4AF1-954F-F89210C2B1AAQ38851261-7C5E4977-BB0F-4E33-8C2D-6AC637EB3F77Q38905356-4569C316-C2DD-4C18-AE2F-0F30E2D66F59Q41040998-6B70E742-CF8C-4B7D-BCB4-3FA89902CAA4Q41947692-5A17A146-45DA-437D-94DA-4A7C61E6A5B6Q44170175-DCF75619-E813-424C-B93F-99D288EA4022Q47966039-3021434E-2E19-4B7C-A4E8-1433D0C4E19DQ49342038-007AE20D-C9A9-460D-9927-FCEE27685129Q54247222-84B1623A-9AF0-497A-8F7A-3924883F43DDQ56352635-3CFE75B9-E366-438A-BA92-66EAF686DD33Q56359785-32ACB4D1-AF4F-4966-B264-E1F3A1BA67C5
P2860
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Randomized, double-blind, plac ...... dults at high risk of malaria.
@ast
Randomized, double-blind, plac ...... dults at high risk of malaria.
@en
type
label
Randomized, double-blind, plac ...... dults at high risk of malaria.
@ast
Randomized, double-blind, plac ...... dults at high risk of malaria.
@en
altLabel
Randomized, double-blind, plac ...... adults at high risk of malaria
@en
prefLabel
Randomized, double-blind, plac ...... dults at high risk of malaria.
@ast
Randomized, double-blind, plac ...... dults at high risk of malaria.
@en
P2093
P2860
P50
P356
P1476
Randomized, double-blind, plac ...... dults at high risk of malaria.
@en
P2093
Elizabeth A Ashley
Niklas Lindegårdh
Phaikyeong Cheah
Warunee Hanpithakpong
P2860
P304
P356
10.1128/AAC.05877-11
P407
P50
P577
2012-01-17T00:00:00Z